$ALTO

Alto (ALTO) Q2 2026 Earnings Call Transcript

Alto Ingredients (ALTO) reported Q2 2026 results in an earnings call. Net sales rose to $245.7M, adjusted EBITDA was $23.7M, and net income attributable to common stockholders was $11.4M ($0.15/diluted share). Full-year Section 45Z guidance is $15M to $16M. Management discussed capacity expansion, CO2 storage, and a $50M at-the-market equity program.

Original reporting
Published Aug 13, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 4:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alto (ALTO) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ALTOBullishMed
01

Why it matters

Key new trading inputs are the quarterly financials, full-year 45Z income guidance ($15M-$16M), and operational/capital plans (Pekin capacity expansion, CO2 storage tank, dock repairs). The risks section adds a near-term macro variable: Middle East geopolitical disruption compressing export arbitrage via higher freight and reduced vessel availability.

02

Market read

This is a company-specific earnings and guidance disclosure with explicit 45Z income range and cash flow and balance-sheet details, likely to drive repricing of near-term earnings quality and credit-driven cash generation.

03

What to watch

The article notes derivative use to limit premium declines and a planned CO2 tank addition by Q4; traders may underweight execution risk and the timing of credit monetization versus reported accrued amounts.

Relevance 9/10Novelty 8/10Timing: post-market Aug. 5, 2026 call and Q2 print

Background

Alto Ingredients held its Q2 2026 earnings call, reporting a profitability turnaround and emphasizing 45Z Clean Fuel Production Credit economics, crush margins, and capacity/capex execution.

Company-level read

Ticker impact

$ALTOBullishMedium confidence
Context

Alto Ingredients reported Q2 results with $245.7M net sales, $23.7M adjusted EBITDA, and guided full-year 45Z income to $15M-$16M.

Expected impact

Near-term bias higher if investors focus on sustained adjusted EBITDA and 45Z monetization; downside risk if freight/geopolitics or premium compression offsets margin gains.

Evidence & confidence

The article discloses multiple decision-relevant datapoints: quarterly profitability turnaround, explicit 45Z income guidance range, and a $50M at-the-market equity program plus capacity debottlenecking. These can re-rate near-term cash flow expectations, though the risks section flags export arbitrage compression.

Market effects

Biofuel/ethanol producers with 45Z exposure may see read-across on how crush margins and credit monetization translate into earnings power.

Middle East freight disruption is cited as a driver of export economics, which can affect US-to-Europe arbitrage for ethanol exports.

Export demand and freight availability are highlighted as key swing factors, linking global shipping conditions to margin outcomes.

Counterpoint

The margin improvement may be partly cyclical (crush margins, export demand) and could fade if premiums over ethanol narrow again or freight conditions normalize unfavorably.

Key entities

  • Alto Ingredients, Inc.

    Subject of the earnings call transcript, reporting Q2 2026 results and full-year 45Z income guidance.

  • Bryon McGregor

    CEO who discussed export economics risk and operational plans tied to profitability.

  • Robert R. Olander

    CFO who discussed 45Z monetization, derivatives used to manage premium declines, and the ATM equity program.

Related articles

$ALTOMed

Alto Ingredients, Inc. (ALTO): Results of Operations and Financial Condition

Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alto Ingredients, Inc. Reports Second Quarter 2026 Results Q2 2026 Gross Profit of $16.6 Million Increased $18.6 Million Q2 2026 Net Income of $11.4 Million, or $0.15 per Share, Improved $22.7 Million Q2 2026 Adjusted EBITDA of $23.7 Million Improved $23.9 Million Pe

$UNFIMedAI 8/10

United Natural Foods (UNFI) Calls the Bottom and Guides for Growth Again

United Natural Foods (UNFI) reported Q4 adjusted EPS of $0.69, beating estimates, but revenue of $7.64B missed expectations. The company guided fiscal 2027 sales to $31.2B-$31.8B, up from $31.15B in 2026. Adjusted EBITDA rose 27% to $701M, and free cash flow hit a record $323M. Management expects fiscal 2027 adjusted EPS of $3.00-$3.50. Hedge fund interest declined in Q2.

MedAI 8/10

LuxExperience B.V. Q4 2026 Earnings Call Summary

LuxExperience B.V. reported Q4 2026 earnings, highlighting EBITDA break-even 15 months post-acquisition. Mytheresa reached EUR 1 billion in sales, while NET-A-PORTER and MR PORTER returned to growth. YOOX cut losses by half. Management expects 2%-3% EBITDA margins in FY 2027 and EUR 4 billion in net sales by 2028. The company improved operational efficiency and strengthened its financial position.

$MOVMed

Movado’s Turnaround Gains Momentum

Movado Group (NYSE: MOV) reported two consecutive quarters of earnings beats, with shares up 60% year-to-date. Analysts rate it a Strong Buy, with an average price target of $40, implying 22% upside. The company benefited from tariff refunds and a shift in consumer preferences toward traditional watches. However, investors should consider potential margin pressures and competition from smartwatches.